Douglas J Lanska MD FAAN MS MSPH (

Dr. Lanska of the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and IM Sechenov First Moscow State Medical University has no relevant financial relationships to disclose.

Originally released April 19, 2000; last updated October 21, 2020; expires October 21, 2023


Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome was first described in Finland, but several patients have been reported from other European and non-European countries. The main features of this autosomal recessive disorder are infantile spasms, severe hypotonia with absence of developmental milestones, blindness, subcutaneous edema of hands and feet, and characteristic dysmorphic features. Data suggest the presence of 1 major locus in the Finnish families with this disorder. In this article, the author describes the main clinical diagnostic findings, emphasizing the early progressive brain atrophy, which starts in the cerebellum and brainstem.

Key points


• PEHO is a neurodegenerative disorder with early infantile onset.


• PEHO and PEHO-like syndrome are clinically and genetically diverse entities.


• PEHO and PEHO-like syndrome may be phenotypic endpoints of many severe genetic encephalopathies.


• The inheritance of PEHO in familial cases is autosomal recessive, although most PEHO-spectrum patients represent sporadic cases.


• PEHO was named according to the main clinical findings: progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy.


• Severe hypotonia, blindness, and edema of face and limbs are typical signs.


• Early brain atrophy, starting in the cerebellum, is the most distinguishing diagnostic feature.

Historical note and terminology

Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) is a progressive infantile brain disorder, first identified by Salonen and colleagues in 14 patients from 11 Finnish families (Salonen et al 1991). The combination of profound mental retardation with epilepsy, absence of developmental milestones, severe hypotonia with hyperreflexia, transient or persistent subcutaneous edema and blindness, together with characteristic dysmorphic features allowed recognition of these patients. It was named according to the main clinical findings (Progressive encephalopathy with Edema, Hypsarrhythmia, and Optic atrophy), and diagnostic clinical criteria were described by Somer (Somer 1993). It is one of the rare Mendelian syndromes with infantile spasms. Haltia and Somer found uniform neuropathological changes with severe neuronal loss in the inner granular layer of the cerebellum in postmortem studies of 8 patients (Haltia and Somer 1993). Neuropathologically, the disorder was referred to as "infantile cerebello-optic atrophy."

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.

Find out how you can join MedLink Neurology